IFNB1 and dengue disease: Using a shared immune profiling approach in two countries, we have documented previously-defined elements of anti-dengue immunity such as elevated levels of activation markers (e.g., CD57 on T cells) and increased production of inflammatory mediators (e.g., IFNβ, perforin, IFNγ) [85].